Annual CFF
$19.60 M
+$19.60 M+100.00%
31 December 2023
Summary:
Minerva Neurosciences annual cash flow from financing activities is currently $19.60 million, with the most recent change of +$19.60 million (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$6.37 million (+48.09%). NERV annual CFF is now -74.40% below its all-time high of $76.57 million, reached on 31 December 2016.NERV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
$0.000.00%
30 September 2024
Summary:
Minerva Neurosciences quarterly cash flow from financing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has increased by +$86.70 thousand (+100.00%). NERV quarterly CFF is now -100.00% below its all-time high of $60.00 million, reached on 31 March 2021.NERV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$0.00
+$86.70 K+100.00%
30 September 2024
Summary:
Minerva Neurosciences TTM cash flow from financing activities is currently $0.00, with the most recent change of +$86.70 thousand (+100.00%) on 30 September 2024. Over the past year, it has dropped by -$19.60 million (-100.00%). NERV TTM CFF is now -100.00% below its all-time high of $89.78 million, reached on 31 March 2015.NERV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NERV Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | +100.0% | -100.0% |
| 3 y3 years | +48.1% | 0.0% | -100.0% |
| 5 y5 years | +686.1% | 0.0% | -100.0% |
NERV Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -67.3% | -100.0% | +100.0% | -100.0% | +100.0% | |
| 5 y | 5 years | -67.3% | +686.1% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -74.4% | +686.1% | -100.0% | +100.0% | -100.0% | +100.0% |
Minerva Neurosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2024 | - | $0.00(0.0%) | -$86.70 K(-100.4%) |
| Mar 2024 | - | $0.00(0.0%) | $19.60 M(0.0%) |
| Dec 2023 | $19.60 M(>+9900.0%) | $0.00(-100.0%) | $19.60 M(0.0%) |
| Sept 2023 | - | -$86.70 K(-100.4%) | $19.60 M(-0.4%) |
| June 2023 | - | $19.69 M(>+9900.0%) | $19.69 M(>+9900.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | $60.00 M(+353.2%) | $0.00(0.0%) | $60.00 M(0.0%) |
| Sept 2021 | - | $0.00(0.0%) | $60.00 M(-10.6%) |
| June 2021 | - | $0.00(-100.0%) | $67.14 M(-7.3%) |
| Mar 2021 | - | $60.00 M(>+9900.0%) | $72.44 M(+447.2%) |
| Dec 2020 | $13.24 M(+2421.5%) | $0.00(-100.0%) | $13.24 M(0.0%) |
| Sept 2020 | - | $7.14 M(+34.5%) | $13.24 M(+116.9%) |
| June 2020 | - | $5.30 M(+565.1%) | $6.10 M(+665.1%) |
| Mar 2020 | - | $797.60 K(>+9900.0%) | $797.60 K(+51.9%) |
| Dec 2019 | $525.00 K(-115.7%) | $0.00(0.0%) | $525.00 K(-23.9%) |
| Sept 2019 | - | $0.00(0.0%) | $690.10 K(-417.9%) |
| June 2019 | - | $0.00(-100.0%) | -$217.10 K(-85.8%) |
| Mar 2019 | - | $525.00 K(+218.0%) | -$1.53 M(-54.3%) |
| Dec 2018 | -$3.34 M | $165.10 K(-118.2%) | -$3.34 M(-30.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$907.20 K(-30.9%) | -$4.78 M(-112.9%) |
| June 2018 | - | -$1.31 M(+1.8%) | $37.10 M(-0.9%) |
| Mar 2018 | - | -$1.29 M(+1.8%) | $37.44 M(-20.6%) |
| Dec 2017 | $47.17 M(-38.4%) | -$1.27 M(-103.1%) | $47.17 M(-2.7%) |
| Sept 2017 | - | $40.97 M(-4321.8%) | $48.49 M(+594.2%) |
| June 2017 | - | -$970.40 K(-111.5%) | $6.99 M(-89.5%) |
| Mar 2017 | - | $8.44 M(>+9900.0%) | $66.46 M(-13.2%) |
| Dec 2016 | $76.57 M(+99.7%) | $55.10 K(-110.3%) | $76.57 M(+0.1%) |
| Sept 2016 | - | -$536.00 K(-100.9%) | $76.51 M(-0.7%) |
| June 2016 | - | $58.50 M(+215.5%) | $77.05 M(+320.7%) |
| Mar 2016 | - | $18.54 M(>+9900.0%) | $18.31 M(-52.2%) |
| Dec 2015 | $38.34 M(-25.7%) | $0.00(0.0%) | $38.34 M(+0.1%) |
| Sept 2015 | - | $0.00(-100.0%) | $38.31 M(-56.8%) |
| June 2015 | - | -$232.20 K(-100.6%) | $88.66 M(-1.2%) |
| Mar 2015 | - | $38.57 M(<-9900.0%) | $89.78 M(+74.0%) |
| Dec 2014 | $51.60 M(+1264.6%) | -$30.30 K(-100.1%) | $51.60 M(-3.7%) |
| Sept 2014 | - | $50.35 M(+5603.9%) | $53.56 M(+1569.2%) |
| June 2014 | - | $882.80 K(+123.7%) | $3.21 M(-23.2%) |
| Mar 2014 | - | $394.60 K(-79.6%) | $4.18 M(+10.4%) |
| Dec 2013 | $3.78 M(+320.2%) | $1.93 M(>+9900.0%) | $3.78 M(+104.4%) |
| Sept 2013 | - | $0.00(-100.0%) | $1.85 M(0.0%) |
| June 2013 | - | $1.85 M(>+9900.0%) | $1.85 M(>+9900.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $900.00 K | - | - |
FAQ
- What is Minerva Neurosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Minerva Neurosciences?
- What is Minerva Neurosciences annual CFF year-on-year change?
- What is Minerva Neurosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Minerva Neurosciences?
- What is Minerva Neurosciences quarterly CFF year-on-year change?
- What is Minerva Neurosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Minerva Neurosciences?
- What is Minerva Neurosciences TTM CFF year-on-year change?
What is Minerva Neurosciences annual cash flow from financing activities?
The current annual CFF of NERV is $19.60 M
What is the all time high annual CFF for Minerva Neurosciences?
Minerva Neurosciences all-time high annual cash flow from financing activities is $76.57 M
What is Minerva Neurosciences annual CFF year-on-year change?
Over the past year, NERV annual cash flow from financing activities has changed by +$19.60 M (+100.00%)
What is Minerva Neurosciences quarterly cash flow from financing activities?
The current quarterly CFF of NERV is $0.00
What is the all time high quarterly CFF for Minerva Neurosciences?
Minerva Neurosciences all-time high quarterly cash flow from financing activities is $60.00 M
What is Minerva Neurosciences quarterly CFF year-on-year change?
Over the past year, NERV quarterly cash flow from financing activities has changed by +$86.70 K (+100.00%)
What is Minerva Neurosciences TTM cash flow from financing activities?
The current TTM CFF of NERV is $0.00
What is the all time high TTM CFF for Minerva Neurosciences?
Minerva Neurosciences all-time high TTM cash flow from financing activities is $89.78 M
What is Minerva Neurosciences TTM CFF year-on-year change?
Over the past year, NERV TTM cash flow from financing activities has changed by -$19.60 M (-100.00%)